Analyst Ratings for Verve Therapeutics (VERV)
VERV Rating Summary
VERV Price Target Summary
- Highest: $13.50 (BMO Capital)
- Lowest: $11.00 (Jefferies)
- Average: $12.38
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$12.38 (+11.2%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 36%
Rating Score: 3.1 / 10
Percentile Rank: 36%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/27/2025 | BMO Capital | Kostas Biliouris | Downgrade | Market Perform (Outperform) |
13.50 (N/A) |
11.21 (11.13) |
-0.71% | Details |
| 6/18/2025 | H.C. Wainwright | Mitchell Kapoor | Downgrade | Neutral (Buy) |
N/A (N/A) |
11.38 (11.13) |
-2.2% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
